Calon Cardio- Technology Ltd
Swansea-based Calon Cardio-Technology Ltd is developing the next generation of implantable micro-pumps for the treatment of heart failure.
It is cutting edge work aimed at making heart assist pumps the routine method of treating heart failure.
"We are developing technology which tackles what is universally recognised as a global health problem of epidemic proportions," said Calon Cardio-Technology managing director Kevin Fernquest.
"We are carrying out very innovative work here in Swansea and make extensive use of computer modelling and simulation in our research and development, which significantly reduces our product development phase and, consequently, the time to market.
"Obviously, access to the very best technology that high performance computing can offer is a major boost for a business like ours.
"I am sure other SMEs in Wales will also welcome the opportunity of accessing the HPC Wales project, which will undoubtedly be a boost for our economy."
Calon's product is a miniature pump that is implanted directly into the failing heart on a long term basis to boost its output. The pump is driven by an embedded electric motor which is powered by a compact battery pack worn by the user.
Mr Fernquest added: "One of the key factors is the speed the super computing process will be able to inject into our work.
"Obviously, with a product like ours, testing it in purely physical conditions is a very time consuming procedure therefore we use computer based simulations to predict potential design issues without having to perform the traditional route of design, manufacture prototypes, test and analyse.
"In short, carrying out an interactive design and simulation phase at the very front end of the design process allows us to create a more efficient product design and test cycle at low cost."
For more information contact: Kevin Fernquest, Managing Director, Calon Cardio-Technology Limited, Institute of Life Science, Swansea University, Singleton Park, Swansea, SA2 8PP, Telephone: 01792 602861 (direct line). Mobile: 0044 (0) 7974807625.
Join the conversation
